Hot Features
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
MYOS RENS TECHNOLOGY BOARD OF DIRECTORS approved the Reverse Stock Split ratio of one new share for every 12 shares of Common Stock outstanding PR Newswire CEDAR KNOLLS, N.J., Nov. 17, 2020 CEDAR...
MYOS RENS Technology Announces anticipated exchange ratio, immediately after the completion of the Merger PR Newswire CEDAR KNOLLS, N.J., Nov. 12, 2020 CEDAR KNOLLS, N.J., Nov. 12, 2020...
MYOS RENS Technology Announces Net Revenues Increase 39% for the Three Months Ended September 30, 2020 Net Revenues Increased 16% for the nine months ended September 30, 2020 PR Newswire CEDAR...
MYOS RENS Technology, Inc. Appoints The S3 Agency to Help Build Awareness of Muscle Health Importance S3 to implement public relations and social media efforts around the ability of Fortetropin®...
MYOS RENS Technology's Net Revenues Increase 114% and Operating Expenses Decrease 26% for the Three Months Ended June 30, 2020 For the six months ended June 30, 2020, Net Revenues Increase 104...
SHAREHOLDER ALERT: WeissLaw LLP Reminds GCAP and MYOS Shareholders About Its Ongoing Investigations PR Newswire NEW YORK, July 24, 2020 NEW YORK, July 24, 2020 /PRNewswire/ -- If...
MYOS RENS Technology Inc. Announces Settlement of Litigation with RENS Technology Inc. PR Newswire CEDAR KNOLLS, N.J., July 16, 2020 CEDAR KNOLLS, N.J., July 16, 2020 /PRNewswire/ -- MYOS RENS...
SHAREHOLDER ALERT: WeissLaw LLP Investigates MYOS RENS Technology Inc. PR Newswire NEW YORK, July 7, 2020 NEW YORK, July 7, 2020 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of...
University of California, Berkeley Researchers Publish Clinical Results Reporting that Fortetropin® Increased the Rate of Muscle Protein Synthesis in Older Adults Men and Women (60-75 Years of...
MYOS RENS Technology and MedAvail Inc. Announce Merger and Spin-Out of Muscle Health Business PR Newswire CEDAR KNOLLS, N.J. and MISSISSAUGA, Ontario, June 30, 2020 CEDAR KNOLLS, N.J. and...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
